FindTrial
Sign In

The role and mechanism of gut microbiota and its metabolites in pregnancies companied with fetal growth restriction

The role and mechanism of gut microbiota and its metabolites in pregnancies companied with fetal growth restriction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055309
Enrollment
Unknown
Registered
2022-01-06
Start date
2022-01-20
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal growth restriction (FGR)

Interventions

normal pregnant woman group:None
fetal growth restriction group:None

Sponsors

Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women with singleton who were registered in Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University for obstetric examination, delivery, voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. History of exposure to radioactive substances and taking teratogenic drugs in the first trimester; 2. High fever (higher than 38.5?) in early pregnancy, family history of hereditary diseases; 3. Consanguineous marriage, chromosomal abnormality of the pregnant woman herself or her husband; 4. Pregnant women with cardiovascular disease, gestational hypertension, diabetes, gestational diabetes, kidney disease, metabolic disease and immune system disease.

Design outcomes

Primary

MeasureTime frame
Neonate birth weight;—

Countries

China

Contacts

Public ContactChen Yi

Beijing Obstetrics and Gynecology Hospital, Capital Medical University

bjfcyycy@sina.com+86 13601354010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026